India, March 12 -- Below are the earnings highlights for Nektar Therapeutics (NKTR):
Earnings: $7.26 million in Q4 vs. -$42.08 million in the same period last year. EPS: $0.03 in Q4 vs. -$0.22 in the same period last year. Analysts projected -$0.19 per share Revenue: $29.175 million in Q4 vs. $23.885 million in the same period last year.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....